Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04759846
Title Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pierre Fabre Medicament

skin melanoma



Binimetinib + Encorafenib

Age Groups: adult | senior
Covered Countries ITA | ESP

Additional content available in CKB BOOST